Results

Total Results: 444 records

Showing results for "malignant neoplasm".

  1. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
    January 01, 2013 - electrolyte disorders 14,325,172 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,114 0.01% 693: Chemotherapy 62,706 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08% 710: Infectious & parasitic diseases including HIV w
  2. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
    January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07% 690 … 18,144 0.13% 692: Radiotherapy 1,115 0.01% 693: Chemotherapy 58,907 0.44% 694: Lymphatic & other malignancies
  3. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
    January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13% 692: Radiotherapy 1,207 0.01% 693: Chemotherapy 61,609 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09% 710: Infectious & parasitic diseases including HIV w
  4. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
    January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14% 692: Radiotherapy 1,534 0.01% 693: Chemotherapy 61,552 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09% 710: Infectious & parasitic diseases including HIV w
  5. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
    January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06% 690 … & neoplasms of uncertain behavior 6,509 0.08% 710: Infectious & parasitic diseases including HIV w
  6. hcup-us.ahrq.gov/reports/statbriefs/sb30.pdf
    May 01, 2007 - TURP—a procedure involving no incision—is most commonly used to treat benign tumors of the prostate, … secondary malignancies, or metastatic cancer. … The following ICD-9-CM diagnosis codes are included in CCS category 29, Prostate Cancer: – 185 Malignantneoplasm of prostate – 233.4 Carcinoma in situ of prostate – V10.46 Personal history of malignantneoplasm—prostate Procedures and Clinical Classifications Software (CCS) The principal procedure
  7. hcup-us.ahrq.gov/reports/statbriefs/sb270-Cancer-Hospitalizations-Adults-2017.pdf
    January 01, 2017 - ■ The most common principal cancer diagnoses in 2017 were secondary malignancies, colorectal cancer … 394.3 Malignant neuroendocrine tumors 13,800 6.9 22,100 3,200 305.0 Head and neck cancers - lip and … The most common adult hospitalizations principally for cancer in 2017 were for secondary malignancies … Aggregate costs were highest for the same set of cancers: secondary malignancies ($3.5 billion), colorectal … of cancer 1,732,900 100.0 Secondary malignancies 569,800 32.9 Respiratory cancers 248,800 14.4 Non-Hodgkin
  8. hcup-us.ahrq.gov/reports/natstats/his96/table1.pdf
    February 11, 2011 - Benign neoplasm of uterus [46.] 222,765 0.64 $8,551 $5,702 $7,746 $10,317 3.0 0.0 … 0.0 43.8 2.16.2 Other and unspecified benign neoplasm 151,779 0.44 $13,848 $5,700 … 2.16.2.2 Benign neoplasm of colon 26,537 0.08 $13,071 $5,756 $9,785 $15,546 5.9 … 0.7 48.5 69.4 2.16.2.3 Benign neoplasm of the thyroid 12,419 0.04 $6,806 $4,265 $5,936 … $8,074 1.7 0.0 18.6 49.3 2.16.2.4 Benign neoplasm of cerebral meninges 12,413 0.04
  9. hcup-us.ahrq.gov/reports/natstats/commdx/table1h.htm
    February 11, 2011 - Cancer of head and neck [11] 4,951 7.17 0.01 … Other and unspecified benign neoplasm [47] 8,188 12.57 0.02 … Secondary malignancies [42] 3,784 5.91 0.01 … Other and unspecified benign neoplasm [47] 8,058 12.64 0.02 … Neoplasms of unspecified nature 2,911 4.65 0.01
  10. hcup-us.ahrq.gov/reports/methods/2006_1.pdf
    January 01, 2006 - For example, if a patient presents with a lump and it is diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should be considered to be present on admission. … For example, “personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3% 174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2% 185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5% 250.00
  11. www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-1996
    January 01, 1996 - cancer appear to be more effective in reducing the size of residual tumor when ovarian cancer is detected … invasive procedures (laparoscopy or laparotomy) to rule out malignancy. … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. … Detection of malignant ovarian neoplasm[s]: a review of the literature. 1. … Elevated serum CA 125 levels prior to diagnosis of ovarian cancer neoplasia: relevance for early detection
  12. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
    January 01, 1998 - cancer of skin 149 0.02 24: Cancer of breast 2373 0.35 25: Cancer of uterus 692 0.10 26: Cancer of … : Cancer of prostate 1786 0.26 30: Cancer of testis 31 0.00 31: Cancer of other male genital organs … , other Unspecified primary 246 0.04 42: Secondary malignancies 5283 0.77 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3740 0.55 46: Benign neoplasm of uterus 4354 0.64 47: Other … unspecified benign neoplasm 2870 0.42 48: Thyroid disorders 681 0.10 49: Diabetes mellitus without
  13. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats.PDF
    January 01, 1998 - cancer of skin 1307 0.02 24: Cancer of breast 23825 0.35 25: Cancer of uterus 7081 0.10 26: Cancer … 29: Cancer of prostate 17389 0.25 30: Cancer of testis 383 0.01 31: Cancer of other male genital … , other Unspecified primary 2048 0.03 42: Secondary malignancies 52242 0.77 43: Malignant neoplasm … 0.12 45: Maintenance chemotherapy, radiotherapy 37316 0.55 46: Benign neoplasm of uterus 44178 0.65 … 47: Other unspecified benign neoplasm 29162 0.43 48: Thyroid disorders 7118 0.10 49: Diabetes mellitus
  14. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10B.PDF
    January 01, 1999 - cancer of skin 128 0.02 24: Cancer of breast 2507 0.35 25: Cancer of uterus 815 0.11 26: Cancer of … : Cancer of prostate 2126 0.30 30: Cancer of testis 40 0.01 31: Cancer of other male genital organs … , other Unspecified primary 192 0.03 42: Secondary malignancies 5080 0.71 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3650 0.51 46: Benign neoplasm of uterus 4972 0.69 47: Other … unspecified benign neoplasm 3463 0.48 48: Thyroid disorders 742 0.10 49: Diabetes mellitus without
  15. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats.PDF
    January 01, 1999 - cancer of skin 1315 0.02 24: Cancer of breast 24405 0.34 25: Cancer of uterus 7566 0.11 26: Cancer … 29: Cancer of prostate 20728 0.29 30: Cancer of testis 393 0.01 31: Cancer of other male genital … , other Unspecified primary 1858 0.03 42: Secondary malignancies 50461 0.70 43: Malignant neoplasm … 0.12 45: Maintenance chemotherapy, radiotherapy 36883 0.51 46: Benign neoplasm of uterus 48732 0.68 … 47: Other unspecified benign neoplasm 34867 0.48 48: Thyroid disorders 7555 0.10 49: Diabetes mellitus
  16. meps.ahrq.gov/survey_comp/MEPS_condition_data.pdf
    January 01, 2009 - include high blood pressure, heart disease, stroke, emphysema, chronic bronchitis, high cholesterol, cancer … diseases  1,993  75.2  12.5  12.4  10, 254–258  Other care and screening  1,866  84.6  2.7  12.7  11–45  Cancer …   1,321  89  1.2  9.9  46, 47  Non‐malignant neoplasm  381  83.6  1.7  14.7  48  Thyroid disease  1,285 … 625,421 14 10, 254–258  Other care and screening 20,347,107 931,518 16 17,219,615 808,617 13 11–45  Cancer … 17,400,124 736,081 19 15,479,928 709,324 17 46, 47  Non-malignant neoplasm 4,708,789 327,107 37 3,936,964
  17. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
    November 08, 2017 - electrolyte disorders 5,377,720 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06% 690 … & neoplasms of uncertain behavior 3,745 0.07% 710: Infectious & parasitic diseases including HIV w
  18. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
    January 01, 2013 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,119,563 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06% 690 … Percent of Total 692: Radiotherapy 664 0.01% 693: Chemotherapy 30,425 0.43% 694: Lymphatic & other malignancies
  19. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
    January 01, 2014 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,071,762 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06% 690 … Percent of Total 692: Radiotherapy 586 0.01% 693: Chemotherapy 29,695 0.42% 694: Lymphatic & other malignancies
  20. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
    January 01, 2012 - electrolyte disorders 3,195,782 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15% 110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG APRDRG Frequency Percent of Total 693: Chemotherapy 32,305 1.01% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01% 710: Infectious & parasitic diseases including HIV w O.R

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive